Keywords
Insulin Growth Factor
How to Cite
Abstract
Lung cancer is one of the diseases which the highest incidence and mortality in the world. Lung cancer consists of small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) with various subtypes. Diabetes mellitus is one of the comorbidities that is often found in lung cancer patients, which is around 6% - 18% in lung cancer patients. Diabetes is a comorbidity factor that has a serious effect in increasing cancer cell progressivity through the activity of insulin growth factor (IGF) which consists of receptors (IGF-R) and binding proteins (IGFP). The role of IGF produces oncogenic mutations at the DNA level with the process of lung cancer immunity stimulates mitogenesis initiated by insulin and initiates neoplasm cells. IGF receptor mechanism has antineoplastic properties, to fulfill glycemia control that will reduce lung cancer progressivity and prevent clinical worsening so that it can help reduce lung cancer mortality with oral hypoglycemia drugs along with lung cancer therapy modalities such as cytotoxic agents, radiotherapy, immunotherapy, and surgery. The role of IGF is to amplify insulin levels in glucose, lipid, and protein metabolism. IGF can induce cell differentiation and initiation of neoplasm. Diabetes mellitus as a comorbidity can poor clinical outcomes and promote progression through IGF receptor activation in the tumorigenesis process.
References
Andayani, N., & Julisafrida, L. (2020). Peranan Immunoterapi Pada Kanker Paru. J Kedokt Syiah Kuala, 20(2), 70–7. https://doi.org/10.24815/jks.v20i2.18499
Danila, E., Zablockis, R., & Gruslys, V. (2020) A Cohort Study of Exposure to Antihyperglycemic Therapy and Survival in Patients with Lung Cancer. Int J Environ Res Public Health, 17(1), 1–12. https://doi.org/10.3390%2Fijerph17051747
Fariz, N., Sita, A., & Fumiyuki, T. (2016). Implications of Insulin-like Growth Factor 1 Receptor Activation in Lung Cancer. Malays J Med Sci, 23(3), 9–21.
Fuentes, N., Rodriguez, M.S., & Silveyra, P. (2021). Role of Sex Hormones in Lung Cancer. Exp Biol Med, 246, 2098–110. https://doi.org/10.1177%2F15353702211019697
Gristina, V., Cupri, M.G., Torchio, M., Mezzogori, C., Cacciabue, L., & Danova, M. (2015). Diabetes and cancer: A critical appraisal of the pathogenetic and therapeutic links. Biomed Reports, 3(2), 131–6. https://doi.org/10.3892%2Fbr.2014.399
Kementerian Kesehatan Republik Indonesia. (2019). Infodatin: Beban Kanker di Indonesia. Jakarta: Kemenkes RI.
Khateeb, J., Fuchs, E., & Khamaisi, M. (2019). Diabetes and Lung Disease: An Underestimated Relationship. Rev Diabet Stud, 15(1), 1– 15. https://doi.org/10.1900%2FRDS.2019.15.1
Kim, J., Lee, H., & Huang, B.W. (2022). Lung Cancer: Diagnosis, Treatment Principles, and Screening. Am Fam Physician, 1(4), 1– 17.
Kurishima, K., Watanabe, H., Ishikawa, H., Satoh, H., & Hizawa, N. (2017). Survival of patients with lung cancer and diabetes mellitus. Mol Clin Oncol, 6(6), 907–10. https://doi.org/10.3892%2Fmco.2017.1224
National Comprehensive Cancer Network. (2018). Small Cell Lung Cancer. Philadelphia.
National Comprehensive Cancer Network. (2020). NCCN Guidelines Version 3.2020: Non- Small Cell Lung Cancer. Philadelphia.
Petrek, H., & Yu, A.M. (2019). MicroRNAs in Non- small Cell Lung Cancer: Gene Regulation, Impact on Cancer Cellular Processes and Therapeutic Potential. Pharmacol Res Perspect, 1–18. https://doi.org/10.1002%2Fprp2.528
Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. Ca Cancer J Clin, 71(3), 209–49. https://doi.org/10.3322/caac.21660
Wang, Z., Li, W., Guo, Q., Wang, Y., Ma, L., & Zhang, X. (2018). Insulin-like Growth Factor-1 Signaling in Lung Development and Inflammatory Lung Diseases. Biomed Res Int, 1(1):17–9. https://doi.org/10.1155/2018/6057589
Xu, J., Bie, F., Wang, Y., Chen, X., Yan, T., & Du, J. (2019). Prognostic Value of IGF-1R in Lung Cancer. Medicine (Baltimore), 98(19), 1–10. https://doi.org/10.1097%2FMD.0000000000015467
Zhao, Z., Zhang, N., Li, A., Zhou, B., Chen, Y., Chen, S., Huang, M., Wu, F., & Zhang, L. (2020). Insulin-like Growth Factor-1 Receptor Induces Immunosuppression in Lung Cancer by Upregulating B7–H4 Expression through the MEK/ERK Signaling Pathway. Cancer Lett, 1(1), 1–10. https://doi.org/10.1016/j.canlet.2020.04.013
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Novita Andayani, Mauliza